Bindley to host life sciences forum to broaden industry connections
August 23, 2013
WEST LAFAYETTE, Ind. - The Bindley Bioscience Center in Purdue University's Discovery Park will host a life sciences forum on Sept. 6 to deepen its industry ties with those in diagnostics and device development, biotechnology, agriculture, pharmaceuticals, and drug discovery and delivery.
The Bindley Bioscience Center Industry Forum, which will include tours of several research laboratories in Discovery Park and meetings with Purdue faculty and scientific directors, runs from 8 a.m. to 5:30 p.m. in the Burton D. Morgan Center for Entrepreneurship, Room 129. The forum, which is free, will conclude with a networking reception from 5:30-7 p.m.
"The leadership of the Bindley Bioscience Center hopes to better understand the research needs of industry, the gap in workforce knowledge and the technical challenges in the coming decade, particularly for those in agriculture, biopharmaceuticals, biotechnology, diagnostics and drug delivery," said Bindley deputy director Joseph Irudayaraj, a biological engineering professor.
"The expected outcome of the industry forum is to create a vision that will tailor research and educational resources that specifically and efficiently prepare Bindley and Purdue to deliver timely solutions that meet the demands of our industry partners."
Tim Sands, Purdue's executive vice president for academic affairs and provost, will provide opening remarks for the Bindley industry forum.
A panel discussion, scheduled from 10 a.m. to noon, will feature industry representatives from Eli Lilly & Co., Dow AgroSciences LLC, Cook Biotech, Ag Alumni Seed, Elanco, Endocyte Inc., Syngenta AG, Roche Diagnostics, BioCrossroads and companies from the Purdue Research Park in West Lafayette.
Joe Pekny, interim director of the Burton D. Morgan Center for Entrepreneurship and a Purdue professor of chemical engineering, will deliver the keynote lecture during lunch.
In addition, Purdue will showcase research laboratories, equipment, expertise and other resources at Bindley and Birck Nanotechnology Center. The research labs focus on the areas of proteomics, metabolomics, cytometry, drug screening and discovery, translational pharmacology, imaging, informatics and bionanotechnology.
Opportunities for technical training and continuing education through a short course, industry-focused series also will be discussed.
To register for the forum, go to https://purdue.qualtrics.com/SE/?SID=SV_bCKT2XZxjmuztOZ. To download the complete schedule, go to http://www.purdue.edu/apps/dpmanage/Resource/1cd0a169fd74471ca666bfa31e952ebd.pdf.
To organize the forum, Bindley officials are working with the Discovery Park Development Office, Office of the Vice President for Research, Office of Technology Commercialization, Discovery Park Engagement, Purdue Foundations and Relations office as well as Purdue colleges and departments across campus.
The Discovery Park center houses the Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), a U.S. Department of Energy-funded Frontiers Research Center. Bindley also is home to the Center for Global Research and Intervention in Infectious Diseases (C-GRID) and plays a key role for the Indiana Clinical and Translational Science Institute. Its Physiological Sensing Facility in Bindley develops and implements innovative multimodal sensors in biological systems.
The Bindley Bioscience Center, which opened to researchers in October 2005, is a 50,000-square-foot research facility that includes 20,000 square feet of laboratory space to facilitate research activity of multiple life sciences teams in parallel. Bindley is named for 1962 Purdue graduate William E. Bindley, who in 2002 contributed $52.5 million to the university. Bindley designated $7.5 million of his gift to cover half the cost of the two-story research facility, with the rest funded by earnings from unrestricted endowments.
A $15.9 million expansion is currently underway adjacent to Bindley. The Multidisciplinary Cancer Research Facility is expected to open in 2014 to enhance the disease research capabilities on campus, integrating scientific expertise from the molecular level through animal disease modeling. The addition will house investigators from the National Cancer Institute-designated Purdue University Center for Cancer Research to work on innovative animal models of disease, development of new therapeutics and in-vivo animal imaging.
Writer: Phillip Fiorini, 765-496-3133, email@example.com
Sources: Joseph Irudayaraj, 765-494-0388, firstname.lastname@example.orgTommy Sors, 765-494-1678, email@example.com